series-c-plus
Stage
1
Investors
About
Ovid Therapeutics is a biopharmaceutical company developing targeted small molecule therapies for rare neurological disorders including genetic epilepsies and neurodevelopmental conditions such as Angelman syndrome.
Explore Ovid Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.